2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Baker Bros. Advisors Lp | — | 11,732,979 | Jun 13, 2022 |
| 667, L.P. | — | 11,732,979 | Jun 13, 2022 |
| Baker Bros. Advisors (GP) LLC | — | 11,732,979 | Jun 13, 2022 |
| Baker Brothers Life Sciences LP | — | 11,732,979 | Jun 13, 2022 |
| Baker Felix | — | 11,732,979 | Jun 13, 2022 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Feb 2, 2026 | Mohideen Pharis | Chief Medical Officer | Sell | 52.5 | -534 | -0.37% | ✗ | $2.6K |
| Jan 12, 2026 | Jan 14, 2026 | BAKER BROS. ADVISORS LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2025 | Dec 19, 2025 | EPIC Bpifrance | Other | Sell | 15.0 | -3,369,093 | -30.91% | ✗ | $15.5M |
| Nov 20, 2025 | Nov 25, 2025 | Mohideen Pharis | Chief Medical Officer | Sell | 91.3 | +35,880 | 32.72% | ✗ | $23.2K |
| Nov 21, 2025 | Nov 24, 2025 | Boucinha Virginie | CFO | Neutral | 90.0 | +32,000 | 84.21% | ✗ | - |
| Nov 21, 2025 | Nov 24, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Neutral | 90.0 | +55,000 | 100.00% | ✗ | - |
| Nov 21, 2025 | Nov 24, 2025 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 12, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 29, 2025 | Jul 31, 2025 | Mohideen Pharis | Chief Medical Officer | Sell | 52.5 | -464 | -0.42% | ✗ | $1K |
| May 22, 2025 | May 27, 2025 | Mohideen Pharis | Chief Medical Officer | Sell | 52.5 | -397 | -0.36% | ✗ | $730.5 |
| May 20, 2025 | EPIC Bpifrance | Other | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 24, 2025 | Bpifrance Investissement S.A.S. | Other | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 7, 2025 | Bpifrance SA | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 27, 2025 | Mar 31, 2025 | BAKER BROS. ADVISORS LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2025 | Jan 31, 2025 | Mohideen Pharis | Chief Medical Officer | Sell | 50.0 | -600 | -0.54% | ✗ | $510 |
| Dec 4, 2024 | Dec 5, 2024 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 22, 2024 | Nov 27, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | 50.0 | -907 | -0.81% | ✗ | $503.3 |
| Nov 21, 2024 | Nov 25, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | 90.0 | +32,650 | 41.14% | ✗ | $1.3K |
| Nov 21, 2024 | Nov 25, 2024 | Boucinha Virginie | CFO | Neutral | 90.0 | +19,000 | 100.00% | ✗ | - |
| Jul 29, 2024 | Jul 31, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | 47.5 | -1,785 | -2.20% | ✗ | $1.7K |
| May 22, 2024 | May 29, 2024 | Mohideen Pharis | Chief Medical Officer | Sell | 27.5 | -1,042 | -1.27% | ✗ | $1.4K |
| Mar 8, 2024 | Mar 11, 2024 | Tasse Daniel | CEO | Buy | 91.3 | +17,094 | 100.00% | ✗ | $14.2K |
| Feb 6, 2024 | Feb 8, 2024 | Ndu Adora | Director | Buy | 90.0 | +1,825 | 100.00% | ✗ | $1.6K |
| Nov 22, 2023 | Dec 19, 2023 | Mohideen Pharis | Chief Medical Officer | Sell | 27.5 | -2,245 | -2.66% | ✗ | $3.9K |
| Nov 20, 2023 | Nov 22, 2023 | Boucinha Virginie | CFO | Neutral | 90.0 | +19,000 | 100.00% | ✗ | - |
| Nov 20, 2023 | Nov 22, 2023 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 20, 2023 | Nov 22, 2023 | Mohideen Pharis | Chief Medical Officer | Neutral | 90.0 | +35,000 | 70.79% | ✗ | - |
| Nov 7, 2023 | Boucinha Virginie | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 25, 2023 | Aug 28, 2023 | MORRIS TIMOTHY E | Director | Buy | 91.3 | +12,000 | 100.00% | ✗ | $18.2K |
| Nov 21, 2022 | Aug 14, 2023 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 29, 2022 | Aug 14, 2023 | Mohideen Pharis | Chief Medical Officer | Sell | 90.0 | +25,239 | 104.29% | ✗ | $6.8K |
| Nov 21, 2022 | Aug 14, 2023 | Robitaille Sebastien | CFO | Neutral | 90.0 | +8,000 | 28.07% | ✗ | - |
| Aug 1, 2023 | Aug 3, 2023 | SOLAND DANIEL B | Director | Buy | 91.3 | +15,000 | 300.00% | ✗ | $24.3K |
| Oct 6, 2022 | Guyot-Caparros Daniele | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 13, 2022 | Jun 13, 2022 | BAKER BROS. ADVISORS LP | Director | Neutral | 90.0 | +11,875,000 | 62.83% | ✗ | - |
| Nov 22, 2021 | Nov 24, 2021 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 22, 2021 | Nov 24, 2021 | Mohideen Pharis | Chief Medical Officer | Neutral | 90.0 | +8,700 | 56.13% | ✗ | - |
| Nov 22, 2021 | Nov 24, 2021 | Robitaille Sebastien | CFO | Neutral | 90.0 | +5,000 | 21.28% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | SOLAND DANIEL B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Ndu Adora | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | MORRIS TIMOTHY E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Monges Viviane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | DE ROSEN MICHEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 11, 2021 | Rao Madduri Ravin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 1, 2021 | Rao Madduri Ravin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 1, 2021 | Ndu Adora | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 2, 2021 | MORRIS TIMOTHY E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 12, 2021 | DE ROSEN MICHEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | GOLLER MICHAEL | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | BAKER BROS. ADVISORS LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Tasse Daniel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | SOLAND DANIEL B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Robitaille Sebastien | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | O'Neill Julie | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Monges Viviane | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Mohideen Pharis | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Giraut Claire | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Ferrere Mailys | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 11, 2021 | Bjerke Torbjorn | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |